BioSpace News Archive

OPKO Health, Inc. announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 9:00 a.m. Eastern time.

PreventionGenetics is excited to announce the availability of their new whole genome sequencing test, PGnome®. Prices start at only $2,490 for testing of a single patient.

Prothena Corporation plc announced that results from Part 1 of the Phase 2 PASADENA study of prasinezumab in early Parkinson’s disease was selected as an oral Top Abstract presentation at the upcoming virtual International Congress of Parkinson’s Disease and Movement Disorders Society.

miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary RNA-targeted therapies with a specific focus on microRNAs, reported financial results for the second quarter ended June 30, 2020 and provided business updates.

ORIC licenses exclusive worldwide development and commercialization rights to a potential best-in-class PRC2 inhibitor

HTG Molecular Diagnostics, Inc., a diagnostic company whose mission is to advance precision medicine, announced that it will report its financial results for the second quarter ended June 30, 2020 after the market close on Tuesday, August 11, 2020.

MannKind Corporation reported financial results for the quarter and six months ended June 30, 2020.

Announced plans to seek approval of Oxbryta for younger pediatric patients in the United States and seek approval of Oxbryta in Europe

OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three and six months ended June 30, 2020.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, reported business highlights and financial results for its fiscal second quarter and six months ended June 30, 2020, and provided an overview of recent progress and accomplishments.